Antibiotics: Cubicin recalled due to presence of glass particles
by Press Release from Outbreak News Today on (#5R2FG)
NewsDesk @bactiman63 Merck announced voluntarily recalling one lot of CUBICIN(R) (daptomycin for injection) 500mg for intravenous use, Lot 934778, Exp June 2022. Because treatment with CUBICIN is likely to be initiated at a hospital or other monitored healthcare setting, the recall is being conducted to the user level, including hospital and administering institutions. Approximately 22,000 vials [...]
The post Antibiotics: Cubicin recalled due to presence of glass particles appeared first on Outbreak News Today.